Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries... Show more
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BRKR declined for three days, in of 297 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on July 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BRKR as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BRKR turned negative on July 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
BRKR broke above its upper Bollinger Band on June 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
BRKR moved above its 50-day moving average on June 23, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BRKR crossed bullishly above the 50-day moving average on June 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BRKR advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 228 cases where BRKR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BRKR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.294) is normal, around the industry mean (24.694). P/E Ratio (32.045) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.002) settles around the average of (0.018) among similar stocks. P/S Ratio (4.615) is also within normal values, averaging (43.458).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRKR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
a manufacturer of analytical and medical instruments
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PGP | 8.28 | 0.05 | +0.61% |
PIMCO Global StockPLUS & Income Fund | |||
IVOL | 19.69 | 0.11 | +0.56% |
Quadratic Intrst Rt Vol & Infl H ETF | |||
TSEP | 22.04 | N/A | N/A |
FT Vest Emerging Mkts Buffr ETF - Sep | |||
ARLU | 28.20 | -0.01 | -0.05% |
AllianzIM U.S. Equity Buffer15 UncAprETF | |||
REGL | 83.28 | -0.14 | -0.17% |
ProShares S&P MidCap 400 Dividend Arst |
A.I.dvisor indicates that over the last year, BRKR has been closely correlated with A. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then A could also see price increases.
Ticker / NAME | Correlation To BRKR | 1D Price Change % | ||
---|---|---|---|---|
BRKR | 100% | -3.89% | ||
A - BRKR | 78% Closely correlated | -2.04% | ||
RVTY - BRKR | 75% Closely correlated | -2.36% | ||
MTD - BRKR | 75% Closely correlated | +0.90% | ||
TMO - BRKR | 69% Closely correlated | -2.41% | ||
WAT - BRKR | 68% Closely correlated | -3.24% | ||
More |